✦ LIBER ✦

Therapeutic use of anti-CTLA-4 antibodies

✍ Scribed by Blank, C. U.; Enk, A.

Book ID: 127201623
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 448 KB
Volume: 27
Category: Article
ISSN: 0953-8178
DOI: 10.1093/intimm/dxu076

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Principles and use of anti-CTLA4 antibod

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

✍ Karl S Peggs; Sergio A Quezada; Alan J Korman; James P Allison 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Cytotoxic T lymphocyte antigen-4 has become recognized as one of the key negative regulators of adaptive immune responses, having a central role in the maintenance of peripheral tolerance and in shaping the repertoire of emergent T cell responses. Concurrent recognition of the potential importance o

Anti–CTLA-4 Antibody Adjuvant Therapy in

Anti–CTLA-4 Antibody Adjuvant Therapy in Melanoma

✍ Alexander M.M. Eggermont; Alessandro Testori; Michele Maio; Caroline Robert 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Anti-CTLA4 antibody clinical trials in m

Anti-CTLA4 antibody clinical trials in melanoma

✍ Antoni Ribas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Clinical Development of the Anti–CTLA-4

Clinical Development of the Anti–CTLA-4 Antibody Tremelimumab

✍ Antoni Ribas 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Ipilimumab: An Anti-CTLA-4 Antibody for

Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma

✍ Lipson, E. J.; Drake, C. G. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 360 KB

Clinical Studies With Anti–CTLA-4 Antibo

Clinical Studies With Anti–CTLA-4 Antibodies in Non-melanoma Indications

✍ Luana Calabrò; Riccardo Danielli; Luca Sigalotti; Michele Maio 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 221 KB